Related Experiment Video
Updated: Oct 13, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Anticytokine Treatment of Rheumatoid Arthritis: An Observational Report
Jacek Lorkowski1, Robert Mętrak2, Barbara Jasiewicz3
1Department of Orthopedics, Traumatology and Sports Medicine, Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland. jacek.lorkowski@gmail.com.
Enbrel (Etanercept) treatment significantly reduced rheumatoid arthritis (RA) disease activity and joint impairment in patients undergoing rehabilitation. This biologic therapy facilitated earlier physical rehabilitation, potentially preventing long-term disability.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) is a disabling autoimmune disease causing joint destruction.
- Current treatments aim to manage inflammation and prevent joint damage.
Purpose of the Study:
- To evaluate the efficacy of Enbrel (Etanercept) in rheumatoid arthritis patients during therapeutic rehabilitation.
- To assess the impact of Enbrel on disease activity and joint function.
Main Methods:
- A cohort of 10 hospitalized RA patients (mean age 32.2 years) received Enbrel 50 mg weekly subcutaneously.
- Disease Activity Score (DAS-28) and Health Assessment Questionnaire (HAQ) were measured 2 months post-treatment initiation.
Main Results:
- The average DAS-28 score decreased from 4.1 to 2.6, indicating significant improvement in 9 patients.
- The average HAQ score improved from 1.5 to 0.6, signifying reduced joint impairment.
Conclusions:
- Enbrel (Etanercept) effectively reduces rheumatoid arthritis disease activity and improves joint function.
- Early initiation of physical rehabilitation, supported by Enbrel therapy, may prevent disability progression.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rheumatic Heart Disease III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The JAK-STAT Signaling Pathway

